ACM
BLRX

ACT Capital Management’s BioLineRX BLRX Stock Holding History

ACT Capital Management’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$25K Hold
688
– – 0.03% 64
2022
Q2 		$35K Hold
688
– – 0.05% 69
2022
Q1 		$47K Hold
688
– – 0.05% 76
2021
Q4 		$56K Hold
688
– – 0.04% 85
2021
Q3 		$76K Hold
688
– – 0.04% 98
2021
Q2 		$78K Buy
+688
New +$80.9K 0.04% 100

Other funds holding BLRX

ACM
Altium Capital Management New York $42M AUM
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $965M AUM 79.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $376B AUM 19.32% 1-Year Est. Return